Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Clinical Lung Cancer|December 10, 2017
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I StudyCarole Massabeau, Jonathan Khalifa, Thomas Filleron, et al.
European Journal of Cancer (Oxford, England : 1990)|November 23, 2013
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinomaJean-Pierre Delord, Josep Tabernero, Rocío García-Carbonero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2020
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 StudyJonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, et al.
Cancers|September 23, 2022
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA StudyDiane Evrard, Clément Dumont, Michel Gatineau, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppressionMélissa Prat, Kimberley Coulson, Clément Blot, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX studyAlain Ravaud, Carlos Gomez-Roca, Marie-Quitterie Picat, et al.
Targeted Oncology|November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trialChristophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Oncoimmunology|November 1, 2021
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancersJuan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, et al.
Targeted Oncology|November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid TumorsJean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyDaniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Pageof 18